• No results found

University of Groningen Ablation of atrial fibrillation de Maat, Gijs Eduard

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Ablation of atrial fibrillation de Maat, Gijs Eduard"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Ablation of atrial fibrillation

de Maat, Gijs Eduard

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

de Maat, G. E. (2018). Ablation of atrial fibrillation: Moving to a heart team approach. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Ablation of atrial fibrillation:

Moving to a heart team approach

(3)

Gijs E. de Maat

Treatment of atrial fibrillation: Moving to a heart team approach ISBN: 978-94-6361-086-5

Copyright © G.E. de Maat, 2018 Groningen

All rights are reserved. No part of this book may be reproduced or transmitted in any form or by any means, without prior written permission of the author.

Cover design Optima Grafische Communicatie Photography: Gijs de Maat

Lay-out and print: Optima Grafische Communicatie

Part of the research described in this thesis was supported by the MD/PhD grant provided by the Junior Scientific Masterclass.

Additional financial support for the publication of this thesis by the following institutions/ companies is gratefully acknowledged: The University of Groningen, Groningen University Institute for Drug Exploration (GUIDE), Hans Huysman Foundation, Atricure, Abbott, Bayer, Biotronik, Boehringer-Ingelheim, ExamVision, Krijnen Medical Innovations, Daiichi Sankyo Nederland, Edwards Lifesciences, Erbe Benelux, Maquet Nederland, Livanova Nederland, Sanofi-Aventis, Vascutek Nederland.

Financial support by the Dutch Heart Foundation for the publication of this thesis is grate-fully acknowledged.

(4)

Ablation of atrial fibrillation:

Moving to a heart team approach

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 25 april 2018 om 12.45 uur

door

Gijs Eduard de Maat

geboren op 15 juni 1985 te Leiden

(5)

Promotores

Prof. dr. M.A. Mariani Prof. dr. I.C. Van Gelder

Copromotores

Dr. M. Rienstra Dr. Y Blaauw

Beoordelingscommissie

Prof. dr. H.J.G.M. Crijns Prof. dr. M.P. Van den Berg Prof. dr. J.G. Grandjean

Paranimfen

Dr. B.A. Mulder Dr. A. Pozzoli

(6)

5

TABlE of ConTEnTs

Chapter 1 General introduction 7

Chapter 2 obesity is associated with impaired long-term success of

pulmonary vein isolation

Open Heart 2018; In press

23

Chapter 3 Relation of overweight and symptomatic Af. A case report

Heart Rhythm Case Reports 2015; 1(5):342-344

37

Chapter 4 What does the blanking period blank? letter to the editors

Journal of Atrial Fibrillation 2015; 31;8(4):1268

43 Chapter 5 surgical versus transcatheter pulmonary vein isolation as first

invasive treatment in patients with atrial fibrillation: a matched group comparison

Europace 2014; 16(1):33-9.

49

Chapter 6 surgical minimally invasive pulmonary vein isolation for lone

atrial fibrillation: mid-term results of a multi-center study

Innovations Technology and Techniques in Cardiothoracic Surgery 2013; 8(6):410-5.

65

Chapter 7 long-term results of surgical minimally invasive pulmonary vein

isolation for paroxysmal lone Af

Europace 2015;17(5):747-52

79

Chapter 8 surgical left atrial appendage exclusion does not impair left atrial contraction function: a pilot study

Biomed Research International: Cardiology 2015; 318901

93

Chapter 9 Impact of thoracoscopic pulmonary vein isolation on right

ventricular function

Biomed Research International: Cardiology 2018; 7392435

107

Chapter 10 Atrial remodeling and function: implications for atrial fibrillation surgery

European Journal of Cardiothoracic Surgery 2018; In press

115

Chapter 11 Discussion and future perspectives 133

Appendices Dutch summary 153

Acknowledgments 157

Curriculum vitea 161

(7)

Referenties

GERELATEERDE DOCUMENTEN

The aim of the present study was to investigate long-term outcome in consecutive patients undergoing a PVI strategy and to assess procedural safety in obese versus non-obese

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical

The early recurrences of arrhythmia such as AF, left atrial tachycardia, atrial flutter are defined as ERAT, reported to occur in up to 40% of patients and they

In present matched study comparing a surgical with transcatheter PVI treat- ment strategy in symptomatic AF patients failed on AADs, but without prior ablations, a surgical

Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation: Single-center experience with 12-month follow-up.

Strength of the present analysis were the long-term follow-up performed by Holter monitoring, the unique patient population with lone paroxysmal atrial fibrillation and the

These novel strain parameters aid to assess the different left atrial functional stages; the reservoir function (storage of PV inflow during ventricular systole),

Exclusion criteria for surgical PVI were left atrial size >55mm (parasternal view), prior transcatheter PVI, prior heart or lung surgery, significant coronary disease or